NCT06571786View on ClinicalTrials.gov

SHAPE for ICP Assessment

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 15, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

August 26, 2025

Conditions
Lumbar Puncture
Interventions
DRUG

Perflutren lipid microsphere

Definity (Lantheus Medical Imaging, N Billerica, MA) in 25 mL of saline infused for up to 6 minutes

Trial Locations (2)

19107

Thomas Jefferson University, Philadelphia

55905

Mayo Clinic, Rochester

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Thomas Jefferson University

OTHER